SIRT1 and esophageal squamous cell carcinoma: confirmed the connection between SIRT1 and metabolic reprogramming, showing that SIRT1 confers resistance in ESCC by upregulating HK2, a key enzyme in glycolysis, thereby increasing tolerance to chemotherapy (207).